RATIONALE: Epigenetic changes to airway cells have been proposed as important modulators of the effects of environmental exposures on airway diseases, yet no study to date has shown epigenetic responses to exposures in the airway that correlate with disease state. The type 2 cytokine IL-13 is a key mediator of allergic airway diseases, such as asthma, and is up-regulated in response to many asthma-promoting exposures. OBJECTIVES: To directly study the epigenetic response of airway epithelial cells (AECs) to IL-13 and test whether IL-13-induced epigenetic changes differ between individuals with and without asthma. METHODS: Genome-wide DNA methylation and gene expression patterns were studied in 58 IL-13-treated and untreated primary AEC cultures and validated in freshly isolated cells of subjects with and without asthma using the Illumina Human Methylation 450K and HumanHT-12 BeadChips. IL-13-mediated comethylation modules were identified and correlated with clinical phenotypes using weighted gene coexpression network analysis. MEASUREMENTS AND MAIN RESULTS: IL-13 altered global DNA methylation patterns in cultured AECs and were significantly enriched near genes associated with asthma. Importantly, a significant proportion of this IL-13 epigenetic signature was validated in freshly isolated AECs from subjects with asthma and clustered into two distinct modules, with module 1 correlated with asthma severity and lung function and module 2 with eosinophilia. CONCLUSIONS: These results suggest that a single exposure of IL-13 may selectively induce long-lasting DNA methylation changes in asthmatic airways that alter specific AEC pathways and contribute to asthma phenotypes.
RATIONALE: Epigenetic changes to airway cells have been proposed as important modulators of the effects of environmental exposures on airway diseases, yet no study to date has shown epigenetic responses to exposures in the airway that correlate with disease state. The type 2 cytokine IL-13 is a key mediator of allergic airway diseases, such as asthma, and is up-regulated in response to many asthma-promoting exposures. OBJECTIVES: To directly study the epigenetic response of airway epithelial cells (AECs) to IL-13 and test whether IL-13-induced epigenetic changes differ between individuals with and without asthma. METHODS: Genome-wide DNA methylation and gene expression patterns were studied in 58 IL-13-treated and untreated primary AEC cultures and validated in freshly isolated cells of subjects with and without asthma using the Illumina Human Methylation 450K and HumanHT-12 BeadChips. IL-13-mediated comethylation modules were identified and correlated with clinical phenotypes using weighted gene coexpression network analysis. MEASUREMENTS AND MAIN RESULTS:IL-13 altered global DNA methylation patterns in cultured AECs and were significantly enriched near genes associated with asthma. Importantly, a significant proportion of this IL-13 epigenetic signature was validated in freshly isolated AECs from subjects with asthma and clustered into two distinct modules, with module 1 correlated with asthma severity and lung function and module 2 with eosinophilia. CONCLUSIONS: These results suggest that a single exposure of IL-13 may selectively induce long-lasting DNA methylation changes in asthmatic airways that alter specific AEC pathways and contribute to asthma phenotypes.
Authors: Weiliang Qiu; Andrea Baccarelli; Vincent J Carey; Nadia Boutaoui; Helene Bacherman; Barbara Klanderman; Stephen Rennard; Alvar Agusti; Wayne Anderson; David A Lomas; Dawn L DeMeo Journal: Am J Respir Crit Care Med Date: 2011-12-08 Impact factor: 21.405
Authors: Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy Journal: Am J Respir Crit Care Med Date: 2009-05-29 Impact factor: 21.405
Authors: S Matsukura; C Stellato; S N Georas; V Casolaro; J R Plitt; K Miura; S Kurosawa; U Schindler; R P Schleimer Journal: Am J Respir Cell Mol Biol Date: 2001-06 Impact factor: 6.914
Authors: Ivana V Yang; Adam Richards; Elizabeth J Davidson; Allen D Stevens; Christena A Kolakowski; Richard J Martin; David A Schwartz Journal: Am J Respir Crit Care Med Date: 2017-03-15 Impact factor: 21.405
Authors: Ivana V Yang; Brent S Pedersen; Andrew H Liu; George T O'Connor; Dinesh Pillai; Meyer Kattan; Rana Tawil Misiak; Rebecca Gruchalla; Stanley J Szefler; Gurjit K Khurana Hershey; Carolyn Kercsmar; Adam Richards; Allen D Stevens; Christena A Kolakowski; Melanie Makhija; Christine A Sorkness; Rebecca Z Krouse; Cynthia Visness; Elizabeth J Davidson; Corinne E Hennessy; Richard J Martin; Alkis Togias; William W Busse; David A Schwartz Journal: J Allergy Clin Immunol Date: 2016-10-13 Impact factor: 10.793
Authors: Avery DeVries; Gabriela Wlasiuk; Susan J Miller; Anthony Bosco; Debra A Stern; I Carla Lohman; Janet Rothers; Anya C Jones; Jessie Nicodemus-Johnson; Monica M Vasquez; John A Curtin; Angela Simpson; Adnan Custovic; Daniel J Jackson; James E Gern; Robert F Lemanske; Stefano Guerra; Anne L Wright; Carole Ober; Marilyn Halonen; Donata Vercelli Journal: J Allergy Clin Immunol Date: 2016-12-21 Impact factor: 10.793
Authors: Aida Habibovic; Milena Hristova; David E Heppner; Karamatullah Danyal; Jennifer L Ather; Yvonne Mw Janssen-Heininger; Charles G Irvin; Matthew E Poynter; Lennart K Lundblad; Anne E Dixon; Miklos Geiszt; Albert van der Vliet Journal: JCI Insight Date: 2016-11-03
Authors: Alejandro A Pezzulo; Rosarie A Tudas; Carley G Stewart; Luis G Vargas Buonfiglio; Brian D Lindsay; Peter J Taft; Nicholas D Gansemer; Joseph Zabner Journal: J Clin Invest Date: 2019-01-14 Impact factor: 14.808
Authors: Jessie Nicodemus-Johnson; Rachel A Myers; Noburu J Sakabe; Debora R Sobreira; Douglas K Hogarth; Edward T Naureckas; Anne I Sperling; Julian Solway; Steven R White; Marcelo A Nobrega; Dan L Nicolae; Yoav Gilad; Carole Ober Journal: JCI Insight Date: 2016-12-08